OMX Nordic 40 2729754 / SE0001809476
2’574.36
Pkt
-0.28
Pkt
-0.01
%
17:35:09
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Neutral | UBS AG | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.02.26 | Volvo AB Hold | Deutsche Bank AG | |
| 19.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 16.02.26 | Volvo AB Buy | UBS AG | |
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Volvo AB Sector Perform | RBC Capital Markets | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | Hennes & Mauritz AB Underweight | Barclays Capital | |
| 12.02.26 | AstraZeneca Halten | DZ BANK | |
| 12.02.26 | Volvo AB Buy | UBS AG | |
| 12.02.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 11.02.26 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 11.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 09.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 09.02.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 06.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 06.02.26 | Novo Nordisk Neutral | UBS AG | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. |